Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

HIV treatment news

Show

From To
Co-administration of rifampicin and efavirenz does not reduce efavirenz concentrations or efficacy

Standard dosing of efavirenz, that was not adjusted for patient weight, resulted in therapeutic efavirenz concentrations and excellent virological outcomes in patients coinfected with TB and HIV

Published
24 July 2012
By
Lesley Odendal
Merck Signs Two Deals for Novel HIV Drug Candidates and Initiates Phase II Clinical Trial of MK-1439 for HIV

Merck has signed licesing deals for two nucleoside reverse transcriptase inhibitors with Chimerix and Yamasa, and will start trials of a new NNRTI shortly.

Published
24 July 2012
From
Merck press release
SOUTH AFRICA: Mother-to-child HIV transmission still falling

South Africa has charted a significant decline in mother-to-child HIV transmission for the second consecutive year, with new data showing that just 2.7 percent of babies born to HIV-positive mums contracted the virus by six weeks of age, compared to 8 percent in 2008.

Published
24 July 2012
From
PlusNews Global
UCSF/SFGH Researchers Call for Change in New FDA Recommendation on HIV and TB Drug Doses

In January, 2012, the U.S. Food and Drug Administration (FDA) issued new guidelines on dosing of an HIV medication used to treat people infected with both HIV and tuberculosis (TB). Now, a new analysis by the University of California, San Francisco (UCSF) and the San Francisco General Hospital and Trauma Center (SFGH) suggests this recommended dose adjustment may not be necessary, particularly in non-Caucasian populations.

Published
24 July 2012
From
USCF News Center
Patient tracing and community dispensing of ARVs keep patients in care

Physical tracing of patients in antiretroviral (ARV) programmes results in a decrease in loss to follow-up, but an increase in reported mortality, according to a systematic review

Published
24 July 2012
By
Lesley Odendal
Changing epidemiology of opportunistic infections in US: still common in inner cities

Large overall declines in opportunistic infections (OIs) among people with HIV in the US mask continued high rates in inner city populations, according to a presentation on

Published
24 July 2012
By
Liz Highleyman
Everything’s different (almost) since last international AIDS conference in U.S.

The United States understands the sea change in AIDS of the past two decades but is unaware of many details of the progress of recent years. It may be that places such as the District of Columbia (HIV prevalence of 2.7 percent) have lessons to learn from places such as Rwanda (HIV prevalence of 2.9 percent), whose response to the AIDS epidemic has been widely praised.

Published
23 July 2012
From
The Washington Post
For Americans with HIV, there are many obstacles to successful treatment

The big issues in HIV treatment in the US are how to find the patients, test them, get them into medical care and keep them there, provide them medicines, educate them and follow their progress.

Published
23 July 2012
From
The Washington Post
International group urges prompt HIV treatment for all

An international group of scientists on Sunday called for all adults who test positive for HIV to be treated with antiretroviral drugs right away rather than waiting for their immune systems to weaken.

Published
23 July 2012
From
Google News
What do people living with HIV think about the prospect of a cure?

The views of people living with HIV and medical researchers about what makes an HIV cure desirable may be very different, and need to be taken into

Published
22 July 2012
By
Keith Alcorn

Filter by country